Therapeutic Asset Ratings
622 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Btx-9341
Breast Cancer
Biotheryx, Inc.
P1
C
(36)
Cadvec
Breast Cancer
Baylor College of Medicine
P1
C
(36)
Cannabis Capsules
Breast Cancer
Tata Memorial Hospital
P1
C
(36)
cct303-406
Breast Cancer
Shanghai PerHum Therapeutics Co., Ltd.
P1
C
(36)
Clr 125
Breast Cancer
Cellectar Biosciences, Inc.
P1
C
(36)
Clsp-1025
Breast Cancer
Clasp Therapeutics, Inc.
P1
C
(36)
Dat-2645
Breast Cancer
Danatlas Pharmaceuticals Co., Ltd
P1
C
(36)
DPA-714
Breast Cancer
University of Alabama at Birmingham
P1
C
(36)
Dpx-Survivac
Breast Cancer
Providence Health & Services
P1
C
(36)
eg017
Breast Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
P1
C
(36)
es2b-c001
Breast Cancer
ExpreS2ion Biotechnologies
P1
C
(36)
esr1 peptide vaccine
Breast Cancer
Herbert Lyerly
P1
C
(36)
FLUOROGLUTAMINE (2S,4R)
Breast Cancer
Abramson Cancer Center at Penn Medicine
P1
C
(36)
FLUORTHANATRACE F-18
Breast Cancer
University of Pennsylvania
P1
C
(36)
Fluzone
Breast Cancer
Rush University Medical Center
P1
C
(36)
Fluzone Quadrivalent
Breast Cancer
Rush University Medical Center
P1
C
(36)
ft536
Breast Cancer
Fate Therapeutics
P1
C
(36)
ft836
Breast Cancer
Fate Therapeutics
P1
C
(36)
gc203 til
Breast Cancer
Shanghai Juncell Therapeutics
P1
C
(36)
Gdc-0587
Breast Cancer
Genentech, Inc.
P1
C
(36)
geh121224
Breast Cancer
GE Healthcare
P1
C
(36)
Gnc-035
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Gnc-077
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Grt-C903
Breast Cancer
National Cancer Institute (NCI)
P1
C
(36)
Grt-R904
Breast Cancer
National Cancer Institute (NCI)
P1
C
(36)
Showing 476 to 500 of 622 assets
Previous
Page 20 of 25
Next